Type 2 diabeTes (T2D) is generally accepted as a complex trait that is under the interacting influence of genetic factors and environmental triggers [1] [2] [3] . Since some individuals are more susceptible to T2D than others, it is essential to clarify inter-individual differences in susceptibility in order to perfect the current therapy and prevention strategies. As yet, single Our results demonstrated that ACE D allele was significantly associated with an increased risk of T2D, and this effect appeared to be additive. Moreover, this association was more prominent for population-based studies and among Africans and Caucasians.
nucleotide polymorphisms or SNPs are considered the major source of genomic variation in determining the inter-individual phenotypic differences [4] . The increasing availability of SNPs has exceedingly accelerated the process of identifying which and how many genetic determinants are implicated in the pathogenesis of T2D [5, 6] . However, until recently the field of as diabetic nephropathy.
Information Extraction
Two authors (W. Niu and Y. Qi) of this article independently summarized the following information from all eligible studies: first author's last name, year of publication, ethnicity of the population studied, study design, number of subjects in each category, baseline characteristics of the study population, and the counts of persons with different genotypes in cases and controls. Besides, information on Hardy-Weinberg equilibrium test was also tracked or calculated manually if unavailable. Finally, any discrepancies were adjudicated by a discussion and a consensus was reached. For the sake of consistency, we converted all continuous variables that were expressed as mean ± standard error (SE) into that as mean ± standard deviation (SD).
Statistical Analysis
The meta-analysis was carried out by using the open-source Review Manager software (version 5.0.19) (http://www.cc-ims.net/revman/download). The Hardy-Weinberg equilibrium was assessed by the χ 2 test (R software version 2.9) for studies without such records. Since no available evidence favored any genetic models of inheritance for the polymorphism under study, we performed additive model (DD versus II and ID versus II), dominant model (DD+ID versus II) and recessive model (DD versus ID+II), respectively.
In general, the fixed-effects model was employed in the absence of between-study heterogeneity (on the basis of the Cochran's Q statistic and I 2 statistic) and otherwise the random-effects model [17] . However, in this meta-analysis, we only used the random-effects model to combine the individual effect-size estimates. This is mainly because within a fixed-effects model, only sampling error contributes to the differences between the observed effect-size estimates across individual studies [18] . Contrastingly, there are two sources of variance coexisted in a random-effects model including the sample error and between-study heterogeneity. Considering the ubiquitous nature of heterogeneity between studies, it is appropriate to utilize a random-effects model [20] .
In addition, subgroup analysis or sensitivity analysis was conducted to seek more narrowly drawn subsets of the studies by removing an individual study each time or studies with the similar features such as deviations from Hardy-Weinberg equilibrium to assess complex disease genetics had been plagued by irreproducibility of published results [7] .
The gene encoding angiotensin converting enzyme (protein: ACE; gene: ACE) has listed as one of the widely evaluated candidates in association with T2D. One polymorphism, insertion/deletion (I/D), in ACE intron 16 attracts special attention since it accounts for approximately half the variance of circulating ACE with D allele correlating with a higher ACE activity [8] . Although a great number of association studies have attempted to link ACE I/D polymorphism to T2D, the results were often not reproducible with published studies showing both positive [9, 10] , null [11, 12] , and negative [13, 14] associations. This lack of reproducibility might stem from a number of causes, relating to study design, sample size and power issues, as well as true variability between populations [15] . In this regard, meta-analysis can provide an opportunity to help identify genetic associations by overcoming the coalescent issues [16] . In order to derive a more precise estimation, we here performed a meta-analysis from all eligible studies to examine the association between ACE I/D polymorphism and T2D risk.
Methods

Publication Search
We screened the relevant studies from the search engines of MEDLINE, EMBASE and Web of Science as of Dec 10, 2009 . As a prerequisite, all studies were published in English and performed in human populations. The combinational key words of 'type 2 or type II' and 'angiotensin or ACE' with either 'gene', 'variant', 'mutation', 'polymorphism', 'allele' or 'genotype' were used. We also extended search spectrum to the "related articles" and the bibliographies of all retrieved studies. If multiple publications from the same study group occurred, we extracted the most complete results for analysis.
Inclusion and Exclusion Criteria
Studies were included if they satisfied the following criteria: (i) evaluation of ACE I/D polymorphism and T2D risk; (ii) retrospective case-control studies using either a hospital-based or a population-based design; (iii) sufficient information upon genotype counts for estimating the odds ratio (OR) and its corresponding 95% confidence interval (CI). We excluded studies that focused on the complicating diseases of T2D such genotype distributions in controls were in agreement with the Hardy-Weinberg equilibrium for all eligible studies at the significant level of 0.05.
Main Meta Results
As shown in Fig. 1 , compared with ACE I allele, presence of D allele conferred a significant risk for T2D (OR=1.33; 95% CI, 1.10-1.61; p=0.003). Except for three studies suggesting the protective effect of D allele [10, 13, 14] and one with the neutral effect [11] , others consistently favored the risk effect, especially for the more recently studies [12, 25] . In addition, under the additive model, this trend was potentiated after comparing homozygotes of D allele with I allele (DD versus II) with a 90% increased risk (95% CI, 1.30-2.78; p=0.0008). In contrast, comparison of ID genotype with II genotype was remarkably attenuated with the ID genotype carriers only had a nonsignificant 11% increased risk for T2D (95% CI, 0.91-1.36; p=0.30) (data not shown).
To generate more information, we accordingly performed both dominant and recessive models of inherence. Overall, the magnitude of association was even stronger in recessive model than in dominant one. In detail, carriers of D allele (both ID and DD genotypes) had a moderate increased risk for T2D compared with the II genotype carriers (OR=1.34; 95% CI, 1.04-1.72; p=0.02) (Fig. 2) , whereas under recessive model this effect was significantly enhanced with a 73% intheir separate influences.
Finally, we assessed the publication bias using the fail-safe number (N fs ) with the significance set at 0.05 for each meta comparison. In detail, if the calculated N fs value was smaller than the number of observed studies, the meta-analysis results might run the risk of having publication bias. We calculated the N fs0.05 according to the formula N fs0.05 =(∑Z/1.64) 2 -k (k is the number of articles included in the meta-analysis).
Results
Study Characteristics
Via an extensive search, there were 14 original articles [9] [10] [11] [12] [13] [14] [20] [21] [22] [23] [24] [25] [26] [27] with 15 study populations that satisfied our inclusion/exclusion criteria totaling 1985 patients with T2D and 4602 controls. Of these 15 populations, five were conducted in a populationbased study design [20, 22, 23, 25] and the remaining in a hospital-based study design [9-14, 21, 24, 26, 27] . In addition, four of these populations were from China [11, 13, 23, 26] , three from Tunisia (Africa) [10, 25] , two from India [14, 24] , two from Turkey [21, 27] and one from Japan [20] , United Kingdom (UK) [22] , Malaysia [9] and Arabs (Asia) [12] , respectively. The baseline characteristics of all eligible studies are summarized in Table 1 . The frequencies of ACE D allele in patients with T2D ranged from 29.3% to 85.3%, and that in controls ranged from 22.9% to 68.8%. The was to a certain extent immune from sample collection. Besides, among 15 study populations, there were 10 hospital-based studies [9-14, 21, 24, 26, 27 ] and 5 population-based studies [20, 22, 23, 25] . After classifying all studies according to study design, it was of interest to note that significant association was consistently observed for the population-based studies but not hospital-based studies (Table 2) . For example, uncreased risk among the DD genotype carriers as compared with the I allele carriers (both ID and II genotypes) (95% CI, 1.26-2.38; p=0.0008) (Fig. 3) .
Subgroup Analysis
The control groups of all studies satisfied the Hardy-Weinberg law for all eligible studies in this meta-analysis, suggesting that the inherited heterogeneity 
Publication Bias
In order to assess the publication bias, we calculated the fail-safe number (N fs ) at the level of 0.05 for each meta comparison. The N fs0.05 values for all the contrasts were greater (ranging from 89 to 281) than the number of studies included (n=15) in the metaanalysis.
discussion
This investigation, including 14 English-published reports totaling 1985 patients with T2D and 4602 conder the recessive model of inheritance, comparison of ACE DD genotype carriers with the II genotype carriers generated no significance among hospital-based studies (OR=1.68; 95% CI, 0.94-3.00; p=0.08), whereas the associated risk was nearly doubled among population-based studies (OR=2.28; 95% CI, 1.44-3.62; p=0.0004).
Furthermore, since 11 of these study populations were from Asia (8 from East Asia and 3 from West Asia), 3 from Africa and 1 from UK, we thus performed subgroup analyses by both continent (Asia, Africa and Europe) and geography (East Asia and West Asia). After classifying all studies according to the continent, we strikingly noticed that statistical significance persisted among populations from Africa and Europe ancestries, whereas no significance from Asia ancestry even within the geographic subgroups for all allele/genotype associations of ACE I/D polymor- er, meta-analysis of multiple studies clearly has a role in offering an association with such potentials [19] .
Based on the current meta-analysis, we have to mention that different study designs might serve as a potential source of between-study heterogeneity by subgroup analyses for ACE I/D polymorphism. Indeed, statistical significance was only observed among studies with a population-based design under both allele association and all genotype genetic models (Table 2 ). In hospital-based studies, poor comparability between cases and controls might confound the true association in light of a regional specialty for the disease under study and the differential hospitalization rates between cases and controls [30] . Since most of our studies recruited subjects from only one hospital, the hospital controls may have a narrower socioeconomic profile. In contrast, controls drawn from the general population might be representative of the true population of those without the disease [31] . It is thus speculated that if involved, the magnitude of association between ACE I/D polymorphism and T2D might be fluctuated among hospital-based studies, which was the case for the present meta-analysis. For example, out of 10 hospital-based studies, three exhibited a protective effect of ACE D allele as compared with I allele, and contrastingly all population-based studied consistently favored the opposite effect. From this respect, the results from the population-based studies might hold the water.
Another potential source of between-study heterogeneity might arise from the different ethnicities since significance was remarkably observed for populations from Africa and Europe ancestries, but null for populations from Asia ancestry (East Asia and West Asia). This inconsistency might involve primarily the following aspects. On one hand, genetic profiles between trols, examined the association of ACE I/D polymorphism with T2D. Overall our results indicated that ACE D allele was significantly associated with an increased risk for T2D and appeared to be inherited additively. Moreover, subgroup analyses indicated that this effect was even more prominent for populationbased studies and among populations from Africa and Europe ancestries.
More recently, a larger meta-analysis involving a total of 24 previous and recent reports by Zhou et al demonstrated that the D allele of ACE I/D polymorphism was significantly associated with an increased risk of T2D compared with the I allele [28] , which was in agreement with the present results. Intuitively, the study by Zhou et al [28] and our study seem to answer the same question regarding whether ACE I/D polymorphism was involved in T2D development via meta-analyses. However, a concerning difference between these two studies was that in this study we excluded T2D patients with other complications such as diabetic nephropathy or retinopathy. Furthermore, expanding their results classified by different ethnic groups, we performed subgroup analyses according to different study designs and highlighted superiority of population-based study over hospital-based study in association studies.
Genetic association studies have a tendency to lack the power to detect a statistically significant association with complex diseases such as T2D, especially for studies with small sample sizes. As illustrated by Cardon and Bell, to generate robust data, a much larger sample involving greater than 1000 subjects in each group might be required, and often more it depends on the prevalence of the polymorphism under study [29] . Currently such a large sample size is an unrealistic goal for many studies. To achieve a satisfactory pow- among different continental or ethnic groups. This study has some limitations worth acknowledging. First, this meta-analysis only focused on published papers written in English; unpublished reports or reports in other languages might bias the present results. Second, the cross-sectional nature of our included studies precludes comments on causality. Third, we only concentrated on T2D as a categorical trait rather than the continuous plasma glucose levels, which runs the risk of losing some information. Fourth, because of limited data, we were unable to perform further subgroup analyses such as by gender and categories of body mass index. Last but not the least, considering the complex genetic network within or between ACE and others that operate in reninangiotensin system, the potential role of I/D polymorphism might be diluted or masked by other gene-gene or gene-environment interactions. Therefore the jury must remain out before the eventual truth prevails.
Taken together, this meta-analysis demonstrated that ACE D allele was significantly associated with an increased risk for T2D and this effect appeared to be inherited additively. Moreover, subgroup analyses further narrowed down this conclusion by showing that the risk effect of D allele was more obvious for population-based studies and among populations from Africa and Europe ancestries. Further studies should investigate the I/D adjacent markers to confirm whether the association is causal or due to LD. different continental populations might vary greatly. Indeed, the frequencies of ACE D allele in cases were exceedingly high among Africans (70.0-85.3%) than among Asians (29.3-56.7%) and UK Caucasians (56.2%), suggesting a possible role of continental differences in genetic backgrounds and the environment that they lived in [32] . In addition, population-stratification might explain this discrepancy. Because all these studies have a high prevalence of ACE D allele and an elevated T2D risk, the I allele might be a marker for these populations in general, rather than a marker for elevated T2D susceptibility. Furthermore, considering the intronic nature of I/D polymorphism, it is possible that this marker may not be a disease-causing locus itself, but may be linked to a causal one. The resulting linkage disequilibrium (LD) will yield a significant association between the marker and hypertension. LD can vary within and between populations because of regional variability of LD, genetic drift, and mating patterns [33] .
On the other hand, as exemplified by a recent datamining study, differences in allele frequencies can result in a reversal of allelic effects where a risk allele is strongly attenuated or become a protective factor in replication studies [34] . In fact, the role of ACE D allele was significantly weakened in Asian replications in this meta-analysis. Moreover, in view of the high prevalence of ACE D allele among all studies, we cannot exclude the possibility that I/D polymorphism may have pleiotropic effects on the pathogenesis of T2D
